Acknowledgments
The authors are thankful to the entire staff of the Pederzoli Hospital of Peschiera del Garda (Verona, Italy) for accepting to participate to this study.
-
Research funding: The authors received no funding for this work.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Informed consent was obtained from all subjects included in this study.
-
Ethical approval: The study protocol (59COVIDCESC; November 3, 2021) was cleared by the Ethics Committee of the Provinces of Verona and Rovigo. All subjects were informed of the study and voluntarily agreed to participate, providing a written consent.
References
1. Callaway, E. The race for coronavirus vaccines: a graphical guide. Nature 2020;580:576–7. https://doi.org/10.1038/d41586-020-01221-y.Search in Google Scholar PubMed
2. Callaway, E. COVID vaccine boosters: the most important questions. Nature 2021;596:178–80. https://doi.org/10.1038/d41586-021-02158-6.Search in Google Scholar PubMed
3. Cohn, BA, Cirillo, PM, Murphy, CC, Krigbaum, NY, Wallace, AW. SARS-CoV-2 vaccine protection and deaths among US veterans during 2021. Science 2021 Nov 4. https://doi.org/10.1126/science.abm0620 [Epub ahead of print].Search in Google Scholar PubMed PubMed Central
4. Thomas, SJ, Moreira, EDJr, Kitchin, N, Absalon, J, Gurtman, A, Lockhart, S, et al.. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N Engl J Med 2021;385:1761–73. https://doi.org/10.1056/nejmoa2110345.Search in Google Scholar
5. Klompas, M. Understanding breakthrough infections following mRNA SARS-CoV-2 vaccination. J Am Med Assoc 2021 Nov 4. https://doi.org/10.1001/jama.2021.19063 [Epub ahead of print].Search in Google Scholar PubMed
6. Mahmoud, SA, Ganesan, S, Naik, S, Bissar, S, Zamel, IA, Warren, KN, et al.. Serological assays for assessing postvaccination SARS-CoV-2 antibody response. Microbiol Spectr 2021;9:e0073321. https://doi.org/10.1128/Spectrum.00733-21.Search in Google Scholar PubMed PubMed Central
7. Padoan, A, Bonfante, F, Cosma, C, Di Chiara, C, Sciacovelli, L, Pagliari, M, et al.. Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers. Clin Chem Lab Med 2021;59:1444–52. https://doi.org/10.1515/cclm-2021-0313.Search in Google Scholar PubMed
8. Feng, S, Phillips, DJ, White, T, Sayal, H, Aley, PK, Bibi, S, et al.. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat Med 2021 Sep 29. https://doi.org/10.1038/s41591-021-01540-1.Search in Google Scholar PubMed PubMed Central
9. Eliakim-Raz, N, Leibovici-Weisman, Y, Stemmer, A, Ness, A, Awwad, M, Ghantous, N, et al.. Antibody titers before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged ≥60 years. J Am Med Assoc 2021 Nov 5. https://doi.org/10.1001/jama.2021.19885 [Epub ahead of print].Search in Google Scholar PubMed PubMed Central
10. Mbaeyi, S, Oliver, SE, Collins, JP, Godfrey, M, Goswami, ND, Hadler, SC, et al.. The Advisory Committee on Immunization Practices’ interim recommendations for additional primary and booster doses of COVID-19 vaccines - United States, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1545–52. https://doi.org/10.15585/mmwr.mm7044e2.Search in Google Scholar PubMed PubMed Central
11. Saciuk, Y, Kertes, J, Shamir Stein, N, Ekka Zohar, A. Effectiveness of a third dose of BNT162b2 mRNA vaccine. J Infect Dis 2021 Nov 2. https://doi.org/10.1093/infdis/jiab556 [Epub ahead of print].Search in Google Scholar PubMed PubMed Central
12. Krammer, F, Srivastava, K, Simon, V. Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine. MedRxiv 2021:21250653. https://doi.org/10.1101/2021.01.29.21250653.Search in Google Scholar
© 2021 Walter de Gruyter GmbH, Berlin/Boston